HK1044957B - 二肽基肽酶i的機械定向抑制劑的醫藥應用 - Google Patents
二肽基肽酶i的機械定向抑制劑的醫藥應用Info
- Publication number
- HK1044957B HK1044957B HK02106536.6A HK02106536A HK1044957B HK 1044957 B HK1044957 B HK 1044957B HK 02106536 A HK02106536 A HK 02106536A HK 1044957 B HK1044957 B HK 1044957B
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- oriented
- medical use
- dipeptidyl peptidase
- hydroxyproline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19834610A DE19834610A1 (de) | 1998-07-31 | 1998-07-31 | Mechanismus-orientierte Inhibitoren der Dipeptidyl Peptidase I |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1044957A1 HK1044957A1 (en) | 2002-11-08 |
HK1044957B true HK1044957B (zh) | 2005-03-18 |
Family
ID=7876021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02106536.6A HK1044957B (zh) | 1998-07-31 | 2002-09-05 | 二肽基肽酶i的機械定向抑制劑的醫藥應用 |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1188765B1 (zh) |
AT (2) | ATE280776T1 (zh) |
DE (3) | DE19834610A1 (zh) |
ES (2) | ES2225370T3 (zh) |
HK (1) | HK1044957B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19940130A1 (de) | 1999-08-24 | 2001-03-01 | Probiodrug Ges Fuer Arzneim | Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung |
US20030130199A1 (en) | 2001-06-27 | 2003-07-10 | Von Hoersten Stephan | Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents |
US7368421B2 (en) | 2001-06-27 | 2008-05-06 | Probiodrug Ag | Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
AU2002328946A1 (en) | 2001-08-13 | 2003-03-03 | Probiodrug Ag | Irreversible cysteine protease inhibitors of legumain |
DE10143840A1 (de) * | 2001-09-06 | 2003-03-27 | Probiodrug Ag | Neue Inhibitoren der Dipeptidylpeptidase I |
US6844316B2 (en) * | 2001-09-06 | 2005-01-18 | Probiodrug Ag | Inhibitors of dipeptidyl peptidase I |
EP1620091B1 (en) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
DK2206496T3 (da) | 2003-05-05 | 2014-12-15 | Probiodrug Ag | Screening af inhibitorer af pyroglutaminsyredannelse i amyloid beta-peptid |
EP1745292A2 (en) * | 2004-04-28 | 2007-01-24 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD158109A1 (de) * | 1981-04-10 | 1982-12-29 | Gunter Fischer | Verfahren zur hemmung der katalytischen aktivitaet von peptidhydrolasen |
DD294711A5 (de) * | 1990-05-25 | 1991-10-10 | Martin-Luther-Universitaet Halle Wittenberg,De | Neue irreversible inhibitoren zur hemmung der katalytischen aktivitaet von enzymen und verfahren zu ihrer herstellung |
-
1998
- 1998-07-31 DE DE19834610A patent/DE19834610A1/de not_active Withdrawn
-
1999
- 1999-08-02 DE DE59910956T patent/DE59910956D1/de not_active Expired - Fee Related
- 1999-08-02 DE DE59905305T patent/DE59905305D1/de not_active Expired - Lifetime
- 1999-08-02 ES ES01121386T patent/ES2225370T3/es not_active Expired - Lifetime
- 1999-08-02 EP EP20010121386 patent/EP1188765B1/de not_active Expired - Lifetime
- 1999-08-02 AT AT01121386T patent/ATE280776T1/de not_active IP Right Cessation
- 1999-08-02 ES ES99115235T patent/ES2199505T3/es not_active Expired - Lifetime
- 1999-08-02 EP EP99115235A patent/EP0995756B1/de not_active Expired - Lifetime
- 1999-08-02 AT AT99115235T patent/ATE239034T1/de not_active IP Right Cessation
-
2002
- 2002-09-05 HK HK02106536.6A patent/HK1044957B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE239034T1 (de) | 2003-05-15 |
DE19834610A1 (de) | 2000-02-24 |
EP0995756B1 (de) | 2003-05-02 |
ES2225370T3 (es) | 2005-03-16 |
DE59905305D1 (de) | 2003-06-05 |
EP1188765A1 (de) | 2002-03-20 |
ATE280776T1 (de) | 2004-11-15 |
EP0995756A2 (de) | 2000-04-26 |
ES2199505T3 (es) | 2004-02-16 |
DE59910956D1 (de) | 2004-12-02 |
EP0995756A3 (de) | 2000-05-03 |
EP1188765B1 (de) | 2004-10-27 |
HK1044957A1 (en) | 2002-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173059A0 (en) | (2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof | |
AU2003282983A8 (en) | Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods | |
SV2003001144A (es) | FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
DE69124371T2 (de) | Typ-iv-dipeptidyl-aminopeptidase-inhibitoren | |
PL1663185T3 (pl) | Zapobieganie i leczenie utraty kości wywołanej przez zapalenie i/lub za pośrednictwem układu odpornościowego | |
AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
EA200200208A1 (ru) | Синергитическая композиция | |
JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
DE60216233D1 (en) | Carbolinderivate | |
ATE326453T1 (de) | Antithrombotische amide | |
PT1307455E (pt) | Inibidores de adesao celular mediada por (alfa)l (beta)2 | |
MXPA03009750A (es) | Compuestos quimicos. | |
MXPA03002911A (es) | Compuestos quimicos. | |
MXPA02012076A (es) | Compuestos quimicos. | |
DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
MXPA02012659A (es) | Derivados de pirazindiona condensados. | |
HK1044957B (zh) | 二肽基肽酶i的機械定向抑制劑的醫藥應用 | |
MXPA03002909A (es) | Compuestos quimicos. | |
MXPA02012470A (es) | Inhibidores de fosfodiesterasa especificos para gmp ciclico. | |
HK1079513A1 (en) | Process for preparing intermediates | |
SI1161239T1 (en) | 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis | |
MXPA03004023A (es) | Compuestos quimicos. | |
SE0102057D0 (sv) | New Salts I | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080802 |